Clinical Trial Update: Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) Versus Combination of Fluticasone Furoate (FlF)/Vilanterol (VI) + Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

View source ↗

Summary

Phase 3 trial update showing non-inferiority of a fixed triple-combination inhaler (beclomethasone dipropionate + formoterol fumarate + glycopyrronium) versus a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide (beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide)
• Fluticasone Furoate/Vilanterol (fluticasone furoate/vilanterol)
• tiotropium bromide (tiotropium)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED